Digestive System Tumor clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Sorry, in progress, not accepting new patients
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.
Orange, California and other locations
Our lead scientists for Digestive System Tumor research studies include Farshid Dayyani.
Last updated: